Header cover image
  • Investing Ideas
  • Nigerian Pharmaceuticals & Biotech High Return On Equity, Low Debt

Nigerian Pharmaceuticals & Biotech High Return On Equity, Low Debt

Results

1

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

May & Baker Nigeria

Market Cap: ₦63.8b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

MAYBAKER

₦37.00

7D

0%

1Y

105.0%